Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4(+) Cell Rises in HIV-Infected Patients

BACKGROUND: Maraviroc treatment for HIV-1 infected patients results in larger CD4(+) T cell rises than are attributable to its antiviral activity alone. We investigated whether this is due to modulation of T cell activation and inflammation. METHODS AND FINDINGS: Thirty maraviroc-treated patients fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Funderburg, Nicholas, Kalinowska, Magdalena, Eason, James, Goodrich, James, Heera, Jayvant, Mayer, Howard, Rajicic, Natasa, Valdez, Hernan, Lederman, Michael M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950842/
https://www.ncbi.nlm.nih.gov/pubmed/20949133
http://dx.doi.org/10.1371/journal.pone.0013188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950842/
https://www.ncbi.nlm.nih.gov/pubmed/20949133
http://dx.doi.org/10.1371/journal.pone.0013188

Ejemplares similares